Hybrid SARS-CoV-2 variants.
作者信息
Rahimi Farid, Talebi Bezmin Abadi Amin
机构信息
Research School of Biology, The Australian National University, Ngunnawal and Ngambri Country, Canberra, Australia.
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
出版信息
Int J Surg. 2022 Jun;102:106656. doi: 10.1016/j.ijsu.2022.106656. Epub 2022 May 6.
Abstract
摘要
相似文献
1
Hybrid SARS-CoV-2 variants.新冠病毒混合变体
Int J Surg. 2022 Jun;102:106656. doi: 10.1016/j.ijsu.2022.106656. Epub 2022 May 6.
2
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月，英国青少年在先前感染和接种疫苗后对 delta（B.1.617.2）和 omicron（B.1.1.529）BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用：一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
3
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
4
A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.一种简单的模型，用于估计 SARS-COV-2 的 Beta、Delta 和 Omicron 变体在南非的传播能力。
Math Biosci Eng. 2022 Jul 22;19(10):10361-10373. doi: 10.3934/mbe.2022485.
5
The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron.SARS-CoV-2 变异株的兴衰与奥密克戎的持续多样化。
Viruses. 2022 Sep 10;14(9):2009. doi: 10.3390/v14092009.
6
Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.奥密克戎变异株对早期流行的 SARS-CoV-2 变异株快速抗原检测的影响。
Microbiol Spectr. 2022 Aug 31;10(4):e0200622. doi: 10.1128/spectrum.02006-22. Epub 2022 Aug 9.
7
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
8
SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant.SARS-CoV-2 的 Alpha、Beta、Delta 和奥密克戎变异株与早期大流行变异株相比，宿主细胞干扰素反应较慢。
Front Immunol. 2022 Sep 30;13:1016108. doi: 10.3389/fimmu.2022.1016108. eCollection 2022.
9
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比，使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
10
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells.SARS-CoV-2 变体在奥密克戎感染细胞中显示出不同的宿主细胞蛋白质组谱，并延迟免疫反应的激活。
Mol Cell Proteomics. 2023 May;22(5):100537. doi: 10.1016/j.mcpro.2023.100537. Epub 2023 Mar 30.
引用本文的文献
1
Co-infection associated with SARS-CoV-2 and their management.与严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）相关的合并感染及其管理。
Future Sci OA. 2023 Feb 3;8(9):FSO819. doi: 10.2144/fsoa-2022-0011. eCollection 2022 Oct.
2
3
Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2.旨在了解新冠病毒杂交/重组变体的免疫学研究。
Vaccines (Basel). 2022 Dec 25;11(1):45. doi: 10.3390/vaccines11010045.
4
Identification of a rare SARS-CoV-2 XL hybrid variant in wastewater and the subsequent discovery of two infected individuals in Nevada.在废水中鉴定出一种罕见的 SARS-CoV-2 XL 杂交变体，并随后在内华达州发现了两名感染者。
Sci Total Environ. 2023 Feb 1;858(Pt 3):160024. doi: 10.1016/j.scitotenv.2022.160024. Epub 2022 Nov 8.
5
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.SARS-CoV-2 疫苗的快速开发：拯救世界的疫苗。
Front Immunol. 2022 Oct 3;13:961198. doi: 10.3389/fimmu.2022.961198. eCollection 2022.
6
Recent review of COVID-19 management: diagnosis, treatment and vaccination.近期对 COVID-19 管理的回顾：诊断、治疗和疫苗接种。
Pharmacol Rep. 2022 Dec;74(6):1120-1148. doi: 10.1007/s43440-022-00425-5. Epub 2022 Oct 10.
7
Omicron variant: Current insights and future directions.奥密克戎变异株：当前的认识和未来方向。
Microbiol Res. 2022 Dec;265:127204. doi: 10.1016/j.micres.2022.127204. Epub 2022 Sep 17.
8
The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic - Correspondence.奥密克戎最新出现的BA.4和BA.5谱系及其在新冠疫情持续蔓延期间引发的全球健康担忧——通信。
Int J Surg. 2022 Jul;103:106698. doi: 10.1016/j.ijsu.2022.106698. Epub 2022 Jun 8.
本文引用的文献
1
Evidence for Recombination as an Evolutionary Mechanism in Coronaviruses: Is SARS-CoV-2 an Exception?冠状病毒中重组作为一种进化机制的证据：严重急性呼吸综合征冠状病毒2是个例外吗？
Front Public Health. 2022 Mar 17;10:859900. doi: 10.3389/fpubh.2022.859900. eCollection 2022.
2
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.严重急性呼吸综合征冠状病毒2型奥密克戎变异株的突变速度比追踪速度还快：刺突蛋白/血管紧张素转换酶2相互作用残基上的多个突变
Immune Netw. 2021 Dec 23;21(6):e38. doi: 10.4110/in.2021.21.e38. eCollection 2021 Dec.
3
From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants.从德尔塔到奥密克戎：SARS-CoV-2 定义变体中的 S1-RBD/S2 突变/缺失平衡。
Gene. 2022 Mar 10;814:146134. doi: 10.1016/j.gene.2021.146134. Epub 2022 Jan 4.
4
The biological and clinical significance of emerging SARS-CoV-2 variants.新兴 SARS-CoV-2 变体的生物学和临床意义。
Nat Rev Genet. 2021 Dec;22(12):757-773. doi: 10.1038/s41576-021-00408-x. Epub 2021 Sep 17.
5
Genomic recombination events may reveal the evolution of coronavirus and the origin of SARS-CoV-2.基因组重组事件可能揭示冠状病毒的进化和 SARS-CoV-2 的起源。
Sci Rep. 2020 Dec 10;10(1):21617. doi: 10.1038/s41598-020-78703-6.
6
Emergence of SARS-CoV-2 through recombination and strong purifying selection.SARS-CoV-2 通过重组和强烈的纯化选择而出现。
Sci Adv. 2020 Jul 1;6(27). doi: 10.1126/sciadv.abb9153. Print 2020 Jul.
7
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.冠状病毒RNA校对：分子基础与治疗靶点
Mol Cell. 2020 Sep 3;79(5):710-727. doi: 10.1016/j.molcel.2020.07.027. Epub 2020 Aug 4.
8
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
9
WHO Declares COVID-19 a Pandemic.世界卫生组织宣布新冠疫情为大流行病。
Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.
10
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
Zotero 插件